Zydus Life gains on deal to launch hypertension drug Riociguat in US

Drug maker Zydus Lifesciences shares rise on partnership with MSN Laboratories for Riociguat tablets launch in the US. Zydus and MSN are the first companies to launch generic Riociguat, indicated for chronic thromboembolic pulmonary hypertension.